Luminist Labs
Diagnostic platform for early detection of liver disease
New York City , US
Medical Devices
Diagnostics
Genomics
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
🏳️
Claim This ListingIs this your company?
Claim this listing to manage your profile, add updates, and connect with your audience.
